Group B Streptococcus real-time PCR may potentially reduce intrapartum maternal antibiotic treatment.
Nir KugelmanShiran KleifeldPninit Shaked-MishanWisam AssafInbal MaromNadav CohenMaya GruberOfer LavieDan WaismanReuven KedarMordehai BardicefAmit DamtiPublished in: Paediatric and perinatal epidemiology (2021)
Compared with antepartum universal culture screening or intrapartum risk-factor assessment, the need for maternal antibiotic treatment may be substantially reduced by implementation of intrapartum GBS real-time PCR, without compromising the sensitivity of GBS detection.